John is a scientist, entrepreneurial investor and operator. His research studies have been cited by nearly 5,000 publications, and his work with stem cells was featured on the cover of Time Magazine. He was one of the first employees of iPierian, a drug discovery startup that was acquired for $725M; iPierian subsequently spun out True North Therapeutics, which was acquired for an additional $825M.